Categories: Bulk Drug

Steps Shasun to dispatch Ranitidine OTC Tablets

Mumbai, February 27, 2018: Pharma real Walks Shasun said it has chosen to dispatch the ‘over the counter’ form of ulcer medicate Ranitidine in 150 mg measurement in the US advertises quickly.

Steps Shasun is now a key player in the US Ranitidine showcase with 32 percent piece of the overall industry through its remedy form in 150 mg and 300 mg measurements.

The new dispatch will additionally fortify organization’s Ranitidine establishment.

As indicated by IRI information, the US OTC market for Ranitidine Tablets, which is the non specific type of the prominent brand Zantac, is around USD 200 million.

This is likewise the principal item endorsement from organization’s 50:50 JV with Vivimed Labs.

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

15 hours ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

2 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

2 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

3 days ago